Please note: In October and November 2010, the MHRA moved from its Market Towers address to a new location on Buckingham Palace Road. Please go to the contact us section of the website for updated contact details.
Page 1
Ref. MDA/2005/041
Issued: 30 June 2005
| IMMEDIATE ACTION |  |
| ACTION | |
| UPDATE | |
| INFORMATION REQUEST |
| Further Information | |||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
DEVICE:
|
|||||||||||||||
| PROBLEM: Recall due to component failure resulting in potential loss of cardioversion, defibrillation and reduced device longevity. |
> |
||||||||||||||
| ACTION BY: All cardiologists and cardiac technicians who implant and manage patients with any of these devices. |
|||||||||||||||
| ACTION: See actions on page 2. |
> |
||||||||||||||
|
DISTRIBUTED to:
* via CE Bulletin |
> |
||||||||||||||
| CONTACTS: Details of manufacturer contacts, National Pacing and ICD Database and MHRA contacts for technical and clinical aspects. Change of address or removal from address list for the Healthcare Commission. |
> |
> Further information supplied in the following pages.
MDA/2005/041 - Guidant implantable cardioverter defibrillators (ICDs) and cardiac resynchronization therapy defibrillators (CRT-Ds). 
